Tri-Service General Hospital

• NCT07597850

  Phase 2, Recruiting, 90 people, 19 May 2026

• NCT05863416

  Phase 4, Completed, 144 people, 18 May 2023

• NCT05606692

  Collaborator, Phase 4, Recruiting, 416 people, 7 Nov 2022

• NCT05331911

  Collaborator, Phase 4, Recruiting, 500 people, 18 Apr 2022

• NCT05141877

  Collaborator, Phase 4, Status unknown, 706 people, 2 Dec 2021

• NCT04046159

  Collaborator, Phase 3, Status unknown, 810 people, 6 Aug 2019

• NCT03443492

  Collaborator, Phase 2, Completed, 130 people, 23 Feb 2018

• NCT03343600

  Collaborator, Phase 2, Terminated, 5 people, 17 Nov 2017

• NCT01864551

  Phase 4, Completed, 60 people, 29 May 2013

• NCT01558011

  Collaborator, Phase 2, Terminated, 51 people, 20 Mar 2012

• NCT01267344

  Collaborator, Phase 2, Completed, 122 people, 28 Dec 2010

• NCT00923000

  Phase 1, Status unknown, 50 people, 18 Jun 2009

• Sex-specific physical activity thresholds influencing muscle function in older adults with XX genotype of ACTN3 R577X

  TSGH_D_113119, 3 Sept 2026

• SGLT2 inhibitors and risk of distant metastasis in patients with breast cancer and type 2 diabetes: a target trial emulation with biological plausibility analysis

  TSGH-D-115176, 28 Jul 2026

• Dynamic conversion and associated risk factors between mutually exclusive muscle health states in geriatric population

  ATSGH-C107-203, 24 Dec 2025

• Glucosamine mitigates hyperglycemic-induced oxidative stress via the SIRT1 pathway in human corneal epithelial cells

  TSGH-D-111-103, TSGH-E-112245, and TSGH-D-113-128, 14 Oct 2025

• Impact of COVID-19 Isolation on Sarcopenia in Older Adults: A Cohort Study from Taiwan

  TSGH-D-112088, 19 Sept 2025

Sources: api.crossref.org

• SGLT2 inhibitors and risk of distant metastasis in patients with breast cancer and type 2 diabetes: a target trial emulation with biological plausibility analysis

  EClinicalMedicine, 7 Aug 2026